Title: AMEND S e n ate Bill No. 1146* House Bill No. 1349
Official Title: AMEND S e n ate Bill No. 1146* House Bill No. 1349
Number of Sections: 3
Source: versions - Amendment SA0259
Media Type: application/pdf
Strikethrough Detection: 3 sections found

================================================================================

Section 1:
Senate Health and Welfare 1
Amendment No. 1 to SB1146
Crowe
Signature of Sponsor
by deleting all language after the enacting clause and substituting:

Section 2:
SECTION 1. Tennessee Code Annotated, Section 38-7-109, is amended by adding the
following as a new subsection:
(c)
(1)
(A) If a county medical examiner's office or regional forensic
center is conducting an autopsy on a decedent who is suspected to have
committed a mass shooting that resulted in the deaths of four (4) or more
individuals, then the county medical examiner or regional forensic center
shall consult such decedent's treating mental health professional or
primary care physician, if known and reasonably able to be identified
through the decedent's next of kin, to obtain information regarding the
decedent's psychotropic drug use.
(B) The county medical examiner shall test the decedent for the
presence of any drugs, including therapeutic levels of psychotropic drugs.
(2)
(A) The county medical examiner's office or regional forensic
center shall disclose the drug use of the decedent to the health science
center and to the department of health.
(B) The county medical examiner's office or regional forensic
center shall not disclose any identifying information including the
SA0259
006069
- 1 -
decedent's name or social security number when disclosing the drug use
of the decedent to the health science center and to the department of
health.
(C) The county medical examiner shall send only a blood sample
of the decedent to the health science center.
(3) The health science center shall study the drug interactions between
the psychotropic drugs and any other drugs that were present in the decedent's
system as provided by the county medical examiner as described in subdivision
(c)(2)(A).
(4) The health science center shall submit quarterly reports of all data
obtained pursuant to this section to the chief clerk of each house of the general
assembly.
(5) As used in this subsection (c):
(1) "Health science center" means the University of Tennessee's
health science center college of pharmacy; and
(2) "Psychotropic drug" means a medication prescribed for the
treatment of mental or behavioral health conditions or a drug prescribed
for any condition that exercises a direct effect upon the central nervous
system and that is capable of influencing and modifying mood,
perceptions, and behavior, including:
(A) Agents for control of mania and depression;
(B) Antidepressants, including selective serotonin
reuptake inhibitors;
(C) Antipsychotics;
(D) Anxiolytics;
(E) Hypnotics;
(F) Mood stabilizers;
- 2 - 006069
(G) Hormonal medication with the primary goal of altering
a person's physical appearance and sexual characteristics
existing at the person's birth;
(H) Psychomotor stimulants;
(I) Stimulants; and
(J) Benzodiazepines.
(6) The county medical examiner, regional forensic center, department of
health, and the health science center must follow all relevant state and federal
privacy laws related to the implementation of this section.

Section 3:
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 3 - 006069
[DELETED:  a HS(((((((]
[DELETED:  -0((((((((((((]
[DELETED:  -0(((((S]


================================================================================

Raw Text:
Senate Health and Welfare 1
Amendment No. 1 to SB1146
Crowe
Signature of Sponsor
AMEND S e n ate Bill No. 1146* House Bill No. 1349
by deleting all language after the enacting clause and substituting:
SECTION 1. Tennessee Code Annotated, Section 38-7-109, is amended by adding the
following as a new subsection:
(c)
(1)
(A) If a county medical examiner's office or regional forensic
center is conducting an autopsy on a decedent who is suspected to have
committed a mass shooting that resulted in the deaths of four (4) or more
individuals, then the county medical examiner or regional forensic center
shall consult such decedent's treating mental health professional or
primary care physician, if known and reasonably able to be identified
through the decedent's next of kin, to obtain information regarding the
decedent's psychotropic drug use.
(B) The county medical examiner shall test the decedent for the
presence of any drugs, including therapeutic levels of psychotropic drugs.
(2)
(A) The county medical examiner's office or regional forensic
center shall disclose the drug use of the decedent to the health science
center and to the department of health.
(B) The county medical examiner's office or regional forensic
center shall not disclose any identifying information including the
SA0259
006069
- 1 -

decedent's name or social security number when disclosing the drug use
of the decedent to the health science center and to the department of
health.
(C) The county medical examiner shall send only a blood sample
of the decedent to the health science center.
(3) The health science center shall study the drug interactions between
the psychotropic drugs and any other drugs that were present in the decedent's
system as provided by the county medical examiner as described in subdivision
(c)(2)(A).
(4) The health science center shall submit quarterly reports of all data
obtained pursuant to this section to the chief clerk of each house of the general
assembly.
(5) As used in this subsection (c):
(1) "Health science center" means the University of Tennessee's
health science center college of pharmacy; and
(2) "Psychotropic drug" means a medication prescribed for the
treatment of mental or behavioral health conditions or a drug prescribed
for any condition that exercises a direct effect upon the central nervous
system and that is capable of influencing and modifying mood,
perceptions, and behavior, including:
(A) Agents for control of mania and depression;
(B) Antidepressants, including selective serotonin
reuptake inhibitors;
(C) Antipsychotics;
(D) Anxiolytics;
(E) Hypnotics;
(F) Mood stabilizers;
- 2 - 006069

(G) Hormonal medication with the primary goal of altering
a person's physical appearance and sexual characteristics
existing at the person's birth;
(H) Psychomotor stimulants;
(I) Stimulants; and
(J) Benzodiazepines.
(6) The county medical examiner, regional forensic center, department of
health, and the health science center must follow all relevant state and federal
privacy laws related to the implementation of this section.
SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.
- 3 - 006069

[DELETED:  a HS(((((((]
[DELETED:  -0((((((((((((]
[DELETED:  -0(((((S]